ConforMIS iTotal® PS Customized Knee Replacement Honored as 2016 Gold Stevie® Award Winner

BEDFORD, Mass., June 21, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced that their newest product to market, the iTotal® PS posterior-stabilized total knee replacement system, was named the winner of the Gold Stevie® Award in the Health & Pharmaceuticals Product category. The Stevie Award, presented by The American Business Awards, recognizes businesses and products that represent important advances in technology and innovation.

http://www.globenewswire.com/NewsRoom/AttachmentNg/ad232976-5886-4977-8505-64b806962bbaPhotos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/210a197f-190c-4959-96cf-6f138a982013

Advertisement

“ConforMIS utilizes proprietary technology to offer a distinctive and innovative product line that represents major advances in joint replacement for patients, surgeons, hospitals and payers,” said Philipp Lang, MD, MBA, Chief Executive Officer and President of ConforMIS. “The full commercial launch of the new iTotal PS customized knee replacement is another example of our dedication to and success in bringing high-quality, award-winning products to market in an expeditious manner. This most recent addition to our product portfolio allows us to greatly expand the number of individual patients that may be treated with our customized knee implants.”

(C) Copyright 2016 GlobeNewswire, Inc. All rights reserved.

Read more: http://www.virtual-strategy.com/2016/06/21/conformis-itotal%C2%AE-ps-customized-knee-replacement-honored-2016-gold-stevie%C2%AE-award-winner#ixzz4CEXGxj99
Follow us: @virtualstrategy on Twitter | VirtualStrategyMagazine on Facebook
Read more at http://www.virtual-strategy.com/2016/06/21/conformis-itotal%C2%AE-ps-customized-knee-replacement-honored-2016-gold-stevie%C2%AE-award-winner#axzz4CE72Ao00#MTx3CO8Af9sSZgqc.99

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement